Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sirona Biochem has formulated a new cancer vaccine antigen so as to give support to the immune system's natural ability to attack cancer.
Subscribe to our email newsletter
The company is developing an antigen found in most human cancers.
Sirona CEO Howard Verrico said vaccines using these antigens have the potential to treat and prevent many forms of cancer including breast, lung, colon and prostate cancer.
"Using our proprietary chemistry technology, we have been able to tap into this challenging chemistry towards developing a stable antigen molecule," Verrico said.